Today ONLY: 4X match

Dear John, I'm thrilled to report that just a few hours into our $150,000 4X Year-End Match Challenge, we've had a tremendous outpouring of support. But we really need the help of everyone in our Alzheimer's Association community to unlock this amazing match before midnight. Can you please take a moment and make a year-end gift now, while it can go 4X as far? John, I know I don't have to tell you how remarkable a 4X match is — particularly today, the last day of 2021. Nor do I need to tell you that this is your last opportunity to make your year-end gift, which may be tax-deductible, to offer compassionate care and support to the more than 6 million Americans living with Alzheimer's disease. So instead, I'll tell you some of the phenomenal things we've accomplished over the last year. Thanks to the incredible support of our community, we were able to: Answer more than 220,000 calls through our 24/7 Helpline (800.272.3900), offering free confidential support and information to people facing Alzheimer's and all other dementia. Invest $70 million in Alzheimer's and dementia research, including more than $59 million in grants to 253 new scientific investigations. Advocate for an increase in Alzheimer's and dementia research at the National Institutes of Health (NIH) of $300 million, bringing federal funding to $3.2 billion annually. And I know that with you by our side, we'll achieve even greater things in 2022. In just a few hours, we'll ring in a new year — with both new opportunities and new challenges. Please help ensure we can provide high-quality care and support and accelerate global research through 2022 and beyond. Make your first gift now, while you can quadruple your impact on our work to offer help and hope to all affected by Alzheimer's. A generous donor who wishes to remain anonymous has pledged to quadruple-match every gift made before midnight tonight, up to a total of $150,000. Their gift will benefit the Tau Pipeline Enabling Program (T-PEP), a funding initiative to accelerate drug development breakthroughs that could help mitigate the toxic effects of tau protein "tangles" in the brain. Because tau tangles are implicated in a number of neurodegenerative disorders, the research made possible by T-PEP could potentially benefit individuals living with Alzheimer's, Parkinson's disease, frontotemporal dementia and more. If you share our donor's commitment to our fight, when you make a gift at this pivotal moment, you can make 4X the impact and make a significant difference in enhancing care and support and advancing research. And, you can even make your year-end gift as a tribute, in honor of a loved one. Can I count on you? Please make your year-end gift now, while it can go 4X as far. Happy New Year, and thank you for your commitment to our fight. Together, we will continue to further our mission to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. With deep appreciation, Donna McCullough Chief Mission and Field Operations Officer P.S. Despite the challenges of this past year, our community stayed strong and united together. And our commitment to those living with Alzheimer's and their caregivers remains unwavering. Please help us end the year strong by donating before midnight, while your gift can still be matched 4X. Thank you.

Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support. Alzheimer's Association Home Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2021 Alzheimer's Association. All rights reserved. 800.272.3900 | alz.org® | Donate Please add [email protected] to your address book to ensure you receive all future emails.   Having trouble reading this email? View it in your browser   View your email preferences or unsubscribe.